Skip to main content

Table 2 Effect of the intervention on HbA1C levels

From: The effects of professional continuous glucose monitoring as an adjuvant educational tool for improving glycemic control in patients with type 2 diabetes

 

Baseline (n = 302)

Three-month (n = 268)

Three-month with baseline observation carried forward (n = 302)

Diff (T-C)

Diff (T-C)

Diff-in-Diff

Diff (T-C)

Diff-in-Diff

β adjusted

β adjusted

β adjusted

β adjusted

β adjusted

HbA1C

1.024*

0.415*

− 0.609**

0.439**

−0.481*

  1. T-intervention group; C-control group; Diff (T-C) and Diff-in-Diff estimator controlled for covariates (sex, age, educational level, nutritional status body mass index, time since diagnosis and type of pharmacological treatment) and the baseline treatment modification
  2. *p < 0.05; **p < 0.01
Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us